Abbott Laboratories shares came under sharp selling pressure following the company's updated guidance issued after its decision to dissolve a partnership or agreement connected to Exact Sciences. The guidance revision spooked investors, triggering a notable decline in the stock. Abbott, a diversified medical device and diagnostics giant, had maintained ties with Exact Sciences, a molecular diagnostics company best known for its Cologuard colorectal cancer screening test. The severance of that relationship appears to have prompted Abbott to reset its financial outlook, which fell short of market expectations. The mechanism is straightforward: losing a commercial or revenue-sharing arrangement with a diagnostics partner reduces near-term revenue visibility, forcing a downward adjustment to forward estimates. Analysts and institutional investors, already scrutinizing Abbott's diagnostics segment following the post-pandemic normalization of COVID testing revenue, now face added uncertainty around the company's growth trajectory. Investors should watch for any updated segment disclosures, analyst estimate revisions, and whether Abbott pursues alternative diagnostics partnerships to offset the commercial gap left by the Exact Sciences split.
Indian startups raised $5.2 billion across 501 deals in H1 2026, down 9% in value but up 7% in deal count year-on-year, per the Inc42 Indian Tech Startup Funding Report. The drop is driven by fewer mega-rounds, while AI funding surged 317% and growth-stage deal activity hit a multi-year high.
The BSE Sensex fell 893 points and the Nifty 50 shed 279 points on June 30, 2026, wiping out roughly Rs 6 lakh crore in investor wealth in a single session. Both indices dropped 1.16%, closing at 76,200.68 and 23,824.10 respectively.
Kotak Mahindra Bank shares fell nearly 3% to Rs 397.6 after CEO Ashok Vaswani announced plans to exit the bank. Investor concern now centres on succession timing and whether the bank's ongoing digital and deposit-growth strategy will stay on track.
South Korea's Kospi dropped 3% at Monday's open while Japan's Nikkei fell 1%, as escalating US-Iran conflict triggered a broad risk-off move across Asian markets. South Korea's heavy reliance on Middle East oil imports makes it especially vulnerable to geopolitical shocks of this kind.
